Business Context and Reporting Period
Company: Docusign, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal Year ended January 31, 2026
Business Overview: Docusign provides the Intelligent Agreement Management (IAM) platform, including eSignature and Contract Lifecycle Management (CLM) solutions. The company serves over 1.8 million customers globally, with a strategic focus on evolving from a pure e-signature provider to a comprehensive agreement management platform powered by AI (Docusign Iris). As of January 31, 2026, IAM represented approximately 10.8% of Annual Recurring Revenue (ARR).
Key Financial Metrics
| Metric (in thousands) | Fiscal 2026 | Fiscal 2025 |
|---|---|---|
| Total Revenue | $3,219,500 | $2,976,739 |
| Subscription Revenue | $3,150,551 (98%) | $2,901,309 (97%) |
| Gross Profit | $2,556,438 | $2,355,080 |
| Gross Margin | 79.4% | 79.1% |
| Operating Income | $298,579 | $199,928 |
| Operating Margin | 9.3% | 6.7% |
| Net Income | $309,085 | $1,067,885 |
| Diluted EPS | $1.48 | $5.08 |
| Operating Cash Flow | $1,165,007 | $1,017,272 |
| Free Cash Flow | $1,058,562 | $920,284 |
| Annual Recurring Revenue (ARR) | $3,272,000 | $3,030,000 |
| Cash & Investments | $1.1 billion | $1.0 billion |
Debt & Liquidity: The company maintains a $750 million secured revolving credit facility (mature May 2030) with no outstanding borrowings as of January 31, 2026. The company is in compliance with all covenants.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 8% year-over-year, driven by a 9% increase in subscription revenue from commercial and enterprise account expansion and digital channel growth.
- Profitability Shift: While GAAP Net Income decreased significantly from $1.07 billion in 2025 to $309 million in 2026, this is primarily due to a one-time $837.3 million tax benefit in 2025 from the release of U.S. federal and state valuation allowances. Operating Income improved by 49% to $298.6 million.
- Expense Management: Operating expenses increased 5% to $2.26 billion. Notably, there were no restructuring charges in 2026 compared to $29.7 million in 2025. Research and Development expenses rose 13% due to workforce investments and the Lexion acquisition integration.
- International Expansion: International revenue grew 13% year-over-year, representing 29% of total revenue.
- Stock Repurchases: The company repurchased 11.8 million shares for $869.1 million during fiscal 2026.
Guidance, Outlook, and Risks
Management Commentary & Strategy:
- IAM Platform: Management is prioritizing the transition to the Intelligent Agreement Management (IAM) platform, which integrates eSignature, CLM, and AI capabilities. IAM is now available across all major geographies.
- Go-to-Market: The company is evolving its sales strategy to an omnichannel approach, balancing direct sales, partner channels, and digital self-service to improve efficiency.
- Billings Metric: Management announced that beginning in fiscal 2027, they will no longer report or guide to "Billings," shifting focus to ARR and other metrics.
Key Risks & Contingencies:
- AI Competition: Rapid advances in AI and Large Language Models (LLMs) could reduce demand for Docusign's solutions or enable competitors to replicate foundational capabilities at lower costs.
- Cybersecurity: The company faces increasing threats from sophisticated cyberattacks, including state-sponsored actors and AI-enhanced phishing, which could damage reputation and incur significant costs.
- Regulatory Environment: Evolving laws regarding data privacy (GDPR, CCPA), e-signature standards, and AI regulation (EU AI Act) could increase compliance costs or limit product functionality.
- Customer Concentration: No single customer accounted for more than 10% of revenue, mitigating concentration risk.
Investor Verification Checklist
- Tax Normalization: Verify the sustainability of the effective tax rate in future periods, given the massive one-time valuation allowance release in 2025 that inflated prior-year net income.
- IAM Adoption Rate: Monitor the growth rate of IAM revenue (currently 10.8% of ARR) to assess the success of the strategic pivot beyond eSignature.
- Stock Repurchase Impact: Review the remaining authorization ($2.6 billion as of March 2026) and the pace of buybacks relative to cash flow generation.
- Operating Leverage: Assess whether the increase in R&D and Sales & Marketing expenses is translating into proportional revenue growth and margin expansion.
- Legal Proceedings: Confirm the status of the securities class action litigation (Weston v. Docusign), which was dismissed in January 2026, and any potential opt-out cases.